Apply Filters
Choose which columns to filter the table by
Select Columns
Choose which columns to display in the table
Holding99 | Sector | Position↕ | Ownership↕ | Shares Δ↕ | Shares Δ % | Market Cap↕ | Owned Since↕ |
|---|---|---|---|---|---|---|---|
1  Incyte INCY | Biotechnology Healthcare | $2.1B 25.6% | 15.88% 30.7M shares | 30.7M → 30.7M +$226.2K | +0.01% | $13.4B Large Cap | ≤ Q2 2013 Held for 12y 4m+ |
2  Acadia Pharmaceuticals ACAD | Biotechnology Healthcare | $925.3M 11.31% | 25.63% 42.9M shares | 42.9M → 42.9M +$405.0K | +0.04% | $3.8B Mid Cap | ≤ Q2 2013 Held for 12y 4m+ |
3  Insmed INSM | Biotechnology Healthcare | $776.2M 9.49% | 4.06% 7.7M shares | 5.4M → 7.7M +$234.7M | +43.35% | $20.1B Large Cap | ≤ Q2 2013 Held for 12y 4m+ |
4  Summit Therapeutics SMMT | Biotechnology Healthcare | $717.6M 8.78% | 4.54% 33.7M shares | 24.4M → 33.7M +$197.9M | +38.07% | $15.5B Large Cap | Q2 2024 Held for 1y 4m |
5  Madrigal Pharmaceuticals, Inc. MDGL | Biotechnology Healthcare | $598.0M 7.31% | 8.9% 2.0M shares | 2.0M → 2.0M +$432.2K | +0.07% | $6.3B Mid Cap | Q2 2016 Held for 9y 4m |
6  Rhythm Pharmaceuticals, Inc. RYTM | Biotechnology Healthcare | $354.1M 4.33% | 8.81% 5.6M shares | — | — | $4.1B Mid Cap | Q4 2017 Held for 7y 10m |
7  Revolution Medicines, Inc. RVMD | Biotechnology Healthcare | $344.5M 4.21% | 5.03% 9.4M shares | 7.9M → 9.4M +$52.5M | +17.99% | $7.5B Mid Cap | Q1 2021 Held for 4y 7m |
8  Kymera Therapeutics KYMR | Biotechnology Healthcare | $290.3M 3.55% | 10.21% 6.7M shares | 6.0M → 6.7M +$28.6M | +10.93% | $3.1B Mid Cap | Q3 2020 Held for 5y 1m |
9  Alkermes ALKS | Biotechnology Healthcare | $183.4M 2.24% | 3.89% 6.4M shares | 4.5M → 6.4M +$55.1M | +42.99% | $4.8B Mid Cap | Q2 2024 Held for 1y 4m |
10  Replimune Group REPL | Biotechnology Healthcare | $102.6M 1.25% | 14.33% 11.0M shares | — | — | $751.6M Small Cap | Q2 2020 Held for 5y 4m |
11  Ultragenyx Pharmaceutical RARE | Biotechnology Healthcare | $100.8M 1.23% | 2.93% 2.8M shares | 1.6M → 2.8M +$43.5M | +75.92% | $3.5B Mid Cap | Q4 2020 Held for 4y 10m |
12  Edgewise Therapeutics, Inc. EWTX | Biotechnology Healthcare | $95.8M 1.17% | 6.94% 7.3M shares | 6.2M → 7.3M +$15.1M | +18.68% | $1.6B Small Cap | Q1 2021 Held for 4y 7m |
13  AbCellera Biologics Inc. ABCL | Biotechnology Healthcare | $94.4M 1.15% | 9.22% 27.5M shares | — | — | $1.1B Small Cap | Q4 2020 Held for 4y 10m |
14  Immunovant, Inc. IMVT | Biotechnology Healthcare | $87.3M 1.07% | 3.19% 5.5M shares | — | — | $2.7B Mid Cap | Q3 2023 Held for 2y 1m |
15  GRAIL, Inc. GRAL | Unknown Unknown | $83.8M 1.02% | 4.53% 1.6M shares | — | — | $1.6B Small Cap | Q4 2024 Held for 10 months |
16  Kiniksa Pharmaceuticals International, plc KNSA | Biotechnology Healthcare | $78.2M 0.956% | 3.87% 2.8M shares | 2.8M → 2.8M +$175.6K | +0.23% | $2.1B Mid Cap | Q2 2018 Held for 7y 4m |
17 BCYC Bicycle Therapeutics BCYC | Unknown Unknown | $75.7M 0.925% | — 10.9M shares | — | — | — — | Q4 2022 Held for 2y 10m |
18 IMCR Immunocore Holdings plc IMCR | Unknown Unknown | $72.9M 0.891% | — 2.3M shares | — | — | — — | Q4 2022 Held for 2y 10m |
19  Celcuity CELC | Biotechnology Healthcare | $72.8M 0.89% | 14.39% 5.5M shares | 4.3M → 5.5M +$15.9M | +28.01% | $460.1M Small Cap | Q3 2023 Held for 2y 1m |
20  Kodiak Sciences Inc KOD | Biotechnology Healthcare | $64.6M 0.79% | 32.81% 17.3M shares | — | — | $190.5M Micro Cap | Q4 2018 Held for 6y 10m |
21  Immatics N.V. IMTX | Biotechnology Healthcare | $54.7M 0.669% | 8.37% 10.2M shares | 7.3M → 10.2M +$15.6M | +39.76% | $661.2M Small Cap | Q3 2020 Held for 5y 1m |
22  Stoke Therapeutics, Inc. STOK | Biotechnology Healthcare | $52.6M 0.643% | 8.49% 4.6M shares | — | — | $628.4M Small Cap | Q3 2022 Held for 3y 1m |
23  Denali Therapeutics Inc. DNLI | Biotechnology Healthcare | $52.2M 0.638% | 2.57% 3.7M shares | — | — | $2.1B Mid Cap | Q1 2020 Held for 5y 7m |
24 GPCR Structure Therapeutics GPCR | Unknown Unknown | $52.0M 0.636% | — 2.5M shares | 361.6K → 2.5M +$44.5M | +593.86% | — — | Q3 2024 Held for 1y 1m |
25  IDEAYA Biosciences, Inc. IDYA | Biotechnology Healthcare | $44.5M 0.545% | 2.42% 2.1M shares | 1.1M → 2.1M +$22.2M | +99.48% | $1.9B Small Cap | Q3 2022 Held for 3y 1m |
26  Nurix Therapeutics, Inc. NRIX | Biotechnology Healthcare | $44.2M 0.541% | 5.09% 3.9M shares | — | — | $912.5M Small Cap | Q3 2020 Held for 5y 1m |
27  Roivant Sciences ROIV | Biotechnology Healthcare | $42.5M 0.519% | 0.554% 3.8M shares | — | — | $7.8B Mid Cap | Q4 2022 Held for 2y 10m |
28 BNTX BioNTech BNTX | Unknown Unknown | $39.3M 0.48% | — 368.9K shares | 45.0K → 368.9K +$34.5M | +719.26% | — — | Q4 2024 Held for 10 months |
29  Entrada Therapeutics TRDA | Biotechnology Healthcare | $32.7M 0.4% | 12.82% 4.9M shares | — | — | $268.7M Micro Cap | Q4 2021 Held for 3y 10m |
30  Merus N.V. MRUS | Biotechnology Healthcare | $30.2M 0.369% | 0.771% 574.4K shares | 223.5K → 574.4K +$18.5M | +156.99% | $4.0B Mid Cap | Q2 2024 Held for 1y 4m |
31  Praxis Precision Medicines, Inc. PRAX | Biotechnology Healthcare | $29.0M 0.355% | 3.38% 689.5K shares | 331.5K → 689.5K +$15.1M | +107.97% | $895.4M Small Cap | Q4 2022 Held for 2y 10m |
32  Intellia Therapeutics NTLA | Biotechnology Healthcare | $25.1M 0.307% | 2.58% 2.7M shares | 644.1K → 2.7M +$19.1M | +315.4% | $991.3M Small Cap | Q4 2024 Held for 10 months |
33  Viridian Therapeutics, Inc. VRDN | Biotechnology Healthcare | $24.4M 0.298% | 2.14% 1.7M shares | 0 → 1.7M +$24.4M | New | $1.2B Small Cap | Q2 2025 Held for 4 months |
34  Monte Rosa Therapeutics, Inc. GLUE | Biotechnology Healthcare | $22.2M 0.271% | 7.99% 4.9M shares | — | — | $291.6M Micro Cap | Q1 2023 Held for 2y 7m |
35 VRNA Verona Pharma VRNA | Unknown Unknown | $21.2M 0.259% | — 223.8K shares | — | — | — — | Q1 2025 Held for 7 months |
36  Vaxcyte, Inc. PCVX | Biotechnology Healthcare | $20.8M 0.255% | 0.497% 640.9K shares | — | — | $4.4B Mid Cap | Q4 2022 Held for 2y 10m |
37 ARGX argenx ARGX | Unknown Unknown | $20.8M 0.255% | — 37.8K shares | 77.8K → 37.8K −$22.0M | -51.44% | — — | Q4 2022 Held for 2y 10m |
38  Verve Therapeutics, Inc. VERV | Biotechnology Healthcare | $19.0M 0.232% | 1.89% 1.7M shares | — | — | — — | Q2 2021 Held for 4y 4m |
39  Cerus CERS | Medical - Devices Healthcare | $18.2M 0.222% | 6.74% 12.9M shares | 19.4M → 12.9M −$9.1M | -33.42% | $261.9M Micro Cap | ≤ Q2 2013 Held for 12y 4m+ |
40  Disc Medicine IRON | Biotechnology Healthcare | $17.9M 0.218% | 0.973% 337.1K shares | 77.1K → 337.1K +$13.8M | +337.44% | $1.9B Small Cap | Q4 2024 Held for 10 months |
41  Akero Therapeutics AKRO | Biotechnology Healthcare | $17.3M 0.212% | 0.407% 324.6K shares | 548.7K → 324.6K −$12.0M | -40.84% | $4.3B Mid Cap | Q3 2020 Held for 5y 1m |
42  Blueprint Medicines BPMC | Biotechnology Healthcare | $16.1M 0.197% | 0.194% 125.5K shares | — | — | — — | Q2 2025 Held for 4 months |
43  Sera Prognostics SERA | Medical - Diagnostics & Research Healthcare | $15.2M 0.186% | 14.59% 5.5M shares | — | — | $76.5M Micro Cap | Q3 2021 Held for 4y 1m |
44  Arrowhead Research ARWR | Biotechnology Healthcare | $14.8M 0.181% | 0.68% 939.2K shares | — | — | $2.2B Mid Cap | Q2 2025 Held for 4 months |
45  Neurogene NGNE | Biotechnology Healthcare | $14.8M 0.181% | 6.95% 991.7K shares | 1.5M → 991.7K −$7.4M | -33.27% | $245.3M Micro Cap | Q4 2023 Held for 1y 10m |
46  Dianthus Therapeutics DNTH | Biotechnology Healthcare | $14.7M 0.18% | 2.46% 789.8K shares | 0 → 789.8K +$14.7M | New | $583.4M Small Cap | Q2 2025 Held for 4 months |
47  Celldex Therapeutics CLDX | Biotechnology Healthcare | $13.5M 0.166% | 1.0% 665.4K shares | 247.6K → 665.4K +$8.5M | +168.68% | $1.4B Small Cap | Q4 2023 Held for 1y 10m |
48  DBV Technologies DBVT | Biotechnology Healthcare | $13.4M 0.164% | 5.34% 1.5M shares | — | — | $233.0M Micro Cap | Q4 2014 Held for 10y 10m |
49  Xenon Pharmaceuticals XENE | Biotechnology Healthcare | $11.6M 0.142% | 0.482% 370.2K shares | 347.4K → 370.2K +$713.6K | +6.56% | $2.5B Mid Cap | Q2 2020 Held for 5y 4m |
50  Cidara Therapeutics CDTX | Biotechnology Healthcare | $11.1M 0.135% | 1.09% 227.3K shares | 0 → 227.3K +$11.1M | New | $980.1M Small Cap | Q2 2025 Held for 4 months |